The Promise of Big Data: Can it Bend the Oncology Cost Curve?
A Comprehensive and Integrated Series of Interventions for Managed Care Professionals

Module 1: The Application of Big Data and Practical Recommendations for Managed Care
Module 2: Opportunities for Big Data to Enhance Appropriate Utilization of Oral Oncology Drugs

• Release date: December 21, 2015
• Expiration date: June 30, 2017
• Estimated Time to Complete Activity: 1.5 hours
• Module 1: 0.75 hour
• Module 2: 0.75 hour
• Compatible with all modern browsers and mobile devices

Distinguished Faculty

Carl V. Asche, MBA, MSc, PhD Research Professor of Medicine Director, Center for Outcomes Research University of Illinois College of Medicine at Peoria Research Professor of Pharmacy Systems, Outcomes and Policy University of Illinois at Chicago College of Pharmacy Click here for biography Diana I. Brixner, RPh, PhD, FAMCP Professor, Department of Pharmacotherapy University of Utah College Of Pharmacy Executive Director, Outcomes Research Center Director of Outcomes, Program in Personalized Health Care Click here for biography Jeffrey D. Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx Pharmacy Services, LLC Click here for biography

Target Audience

• Managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals with an interest in big data to improve the quality of care in oncology

Statement of Need/Program Overview
In health care, big data is being used to guide treatments, improve clinical research, identify challenges and opportunities, and provide real-time information and learning to clinicians and payers. The field of oncology has always used big data to track epidemiology and clinical trial outcomes. However, there is a significant need for clinicians and payers to begin mining the billions of bits of data available in disparate systems to improve the delivery of care, provide personalized care, identify important areas of research, evaluate real-life efficacy of clinical guidelines, and assess the value (quality/cost) of current therapies. Education is needed for the target audience to obtain the knowledge and competency to implement big data initiatives to successfully transition to a value-based reimbursement model.  Emerging analyses, practical examples, and expert recommendations will be formulated to illuminate key learnings using general oncology as the therapeutic area of focus.

Module 1 Educational Objectives
After completing this activity, the participant should be better able to:

• Describe the elements of a learning health care system including the potential role of big data for improving the quality of care in oncology
• Discuss the role of big data in the delivery of personalized medicine
• Identify case studies and other examples of oncology-based big data initiatives currently underway
• Provide accurate and appropriate counsel as part of the managed care treatment team
• Provide appropriate care and counsel for patients and their families

Module 2 Educational Objectives
After completing this activity, the participant should be better able to:

• Discuss the potential of big data to improve evidence-based prescribing and appropriate utilization of oncology therapies
• Identify opportunities to use big data to successfully transition to a value-based reimbursement model
• Describe the challenges of implementing big data initiatives including the opportunities to overcome those challenges
• Provide accurate and appropriate counsel as part of the managed care treatment team
• Provide appropriate care and counsel for patients and their families

ACCREDITATION

Physician Continuing Medical Education

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation (all modules)
Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Module 1: 0.75 CME credits
• Module 2: 0.75 CME credits

Pharmacist Continuing Education

	Pharmacist Accreditation Statement  Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

• Module 1: UAN: 0809-9999-15-296-H01-P, 0.75 contact hour (knowledge)
• Module 2: UAN: 0809-9999-15-300-H01-P, 0.75 contact hour (knowledge)

Upon completion of the activity evaluation, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

Nursing Continuing Education

Credit Designation
This educational activity for 1.5 contact hours is provided by Postgraduate Institute for Medicine.

• Module 1: 0.7 contact hours
• Module 2: 0.8 contact hours

Nursing Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A statement of credit will be issued only upon receipt of a completed activity evaluation form.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period December 21, 2015 through June 30, 2017, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, your certificate will be made available immediately to download and print.

For Pharmacists: Upon completion of the activity evaluation, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

MEDIA
Internet

FEE INFORMATION
There is no fee for this educational activity.